Patrick Zuber

766 total citations
20 papers, 429 citations indexed

About

Patrick Zuber is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Patrick Zuber has authored 20 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 13 papers in Health and 7 papers in Epidemiology. Recurrent topics in Patrick Zuber's work include Vaccine Coverage and Hesitancy (13 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Viral gastroenteritis research and epidemiology (6 papers). Patrick Zuber is often cited by papers focused on Vaccine Coverage and Hesitancy (13 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Viral gastroenteritis research and epidemiology (6 papers). Patrick Zuber collaborates with scholars based in Switzerland, United States and United Kingdom. Patrick Zuber's co-authors include Umesh D. Parashar, Julie E. Bines, Souleymane Kone, Divya Parmar, Miriam Sturkenboom, Robert T. Chen, Penina Haber, Manish M. Patel, James Baggs and Daniel Weibel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Vaccine and BMC Medicine.

In The Last Decade

Patrick Zuber

20 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Zuber Switzerland 12 221 216 155 46 41 20 429
Maurice Gatera Rwanda 10 175 0.8× 179 0.8× 363 2.3× 85 1.8× 68 1.7× 14 579
Cuauhtémoc Ruiz‐Matus United States 16 225 1.0× 188 0.9× 424 2.7× 85 1.8× 26 0.6× 20 657
Sofía Minguell Spain 13 78 0.4× 180 0.8× 294 1.9× 53 1.2× 26 0.6× 43 480
Novilia Sjafri Bachtiar Indonesia 11 78 0.4× 345 1.6× 97 0.6× 19 0.4× 56 1.4× 40 510
Ian D. Plumb United States 12 107 0.5× 322 1.5× 166 1.1× 17 0.4× 28 0.7× 42 596
Maria Serena Gallone Italy 12 234 1.1× 157 0.7× 198 1.3× 44 1.0× 21 0.5× 28 445
Andrea Vicari United States 11 130 0.6× 89 0.4× 341 2.2× 21 0.5× 87 2.1× 30 534
Adrienne Guignard Belgium 12 108 0.5× 124 0.6× 310 2.0× 39 0.8× 50 1.2× 34 569
John W. Fitzsimmons United States 8 143 0.6× 154 0.7× 135 0.9× 27 0.6× 12 0.3× 10 398
Alexis Pillsbury Australia 12 224 1.0× 126 0.6× 471 3.0× 13 0.3× 104 2.5× 19 619

Countries citing papers authored by Patrick Zuber

Since Specialization
Citations

This map shows the geographic impact of Patrick Zuber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Zuber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Zuber more than expected).

Fields of papers citing papers by Patrick Zuber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Zuber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Zuber. The network helps show where Patrick Zuber may publish in the future.

Co-authorship network of co-authors of Patrick Zuber

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Zuber. A scholar is included among the top collaborators of Patrick Zuber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Zuber. Patrick Zuber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salmon, Daniel A., P H Lambert, Hanna Nohynek, et al.. (2021). Novel vaccine safety issues and areas that would benefit from further research. BMJ Global Health. 6(Suppl 2). e003814–e003814. 8 indexed citations
2.
Zuber, Patrick, et al.. (2021). Evolving pharmacovigilance requirements with novel vaccines and vaccine components. BMJ Global Health. 6(Suppl 2). e003403–e003403. 12 indexed citations
3.
Conklin, Laura, Anders Hviid, Walter A. Orenstein, et al.. (2021). Vaccine safety issues at the turn of the 21st century. BMJ Global Health. 6(Suppl 2). e004898–e004898. 31 indexed citations
4.
5.
Plotkin, Stanley A., Paul A. Offit, Frank DeStefano, et al.. (2020). The science of vaccine safety: Summary of meeting at Wellcome Trust. Vaccine. 38(8). 1869–1880. 18 indexed citations
6.
Karimi, Abdollah, et al.. (2019). Complications following Bacille Calmette-Guérin Vaccination in Children under the Age of 18 Months: A Multi-center Study. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Mungwira, Randy G., Christine Maure, & Patrick Zuber. (2019). Economic and immunisation safety surveillance characteristics of countries implementing no-fault compensation programmes for vaccine injuries. Vaccine. 37(31). 4370–4375. 7 indexed citations
8.
Cohen, Adam L., Negar Aliabadi, Fatima Serhan, et al.. (2018). Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction. Vaccine. 36(51). 7755–7758. 2 indexed citations
9.
Akanmori, Bartholomew D., et al.. (2018). Vaccine Safety and Pharmacovigilance in the African Region: Recent updates. 2(SI1). 80–88. 8 indexed citations
10.
Wilder‐Smith, Annelies, Ira M. Longini, Patrick Zuber, et al.. (2017). The public health value of vaccines beyond efficacy: methods, measures and outcomes. BMC Medicine. 15(1). 138–138. 68 indexed citations
11.
12.
Chen, Robert T., Tom T. Shimabukuro, David Martin, et al.. (2015). Enhancing vaccine safety capacity globally: A lifecycle perspective. Vaccine. 33(6 Suppl 4). D46–D54. 41 indexed citations
13.
Izurieta, Héctor S., Patrick Zuber, Jan Bonhoeffer, et al.. (2013). Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines. Vaccine. 31(35). 3623–3627. 21 indexed citations
14.
Bonhoeffer, Jan, Steve Black, Héctor S. Izurieta, Patrick Zuber, & Miriam Sturkenboom. (2012). Current status and future directions of post-marketing vaccine safety monitoring with focus on USA and Europe. Biologicals. 40(5). 393–397. 20 indexed citations
15.
Tate, Jacqueline E., A. Duncan Steele, Julie E. Bines, Patrick Zuber, & Umesh D. Parashar. (2012). Research priorities regarding rotavirus vaccine and intussusception: A meeting summary. Vaccine. 30. A179–A184. 24 indexed citations
16.
Zuber, Patrick, et al.. (2011). Sustaining GAVI-supported vaccine introductions in resource-poor countries. Vaccine. 29(17). 3149–3154. 15 indexed citations
17.
18.
Patel, Manish M., Penina Haber, James Baggs, et al.. (2009). Intussusception and rotavirus vaccination: a review of the available evidence. Expert Review of Vaccines. 8(11). 1555–1564. 59 indexed citations
19.
Zuber, Patrick, et al.. (2008). Forecasting demand for Hib-containing vaccine in the world's poorest countries: A 4-year prospective experience. Vaccine. 27(3). 410–415. 5 indexed citations
20.
Zuber, Patrick, et al.. (2007). Introduction of Hib vaccine into national immunization programmes: A descriptive analysis of global trends. Vaccine. 25(41). 7075–7080. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurice Gatera Breakdown of academic impact, for papers by Cuauhtémoc Ruiz‐Matus Breakdown of academic impact, for papers by Sofía Minguell Breakdown of academic impact, for papers by Novilia Sjafri Bachtiar Breakdown of academic impact, for papers by Ian D. Plumb Breakdown of academic impact, for papers by Maria Serena Gallone Breakdown of academic impact, for papers by Andrea Vicari Breakdown of academic impact, for papers by Adrienne Guignard Breakdown of academic impact, for papers by John W. Fitzsimmons Breakdown of academic impact, for papers by Alexis Pillsbury
Rankless by CCL
2026